Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sack

Showing results (201-210 of 245) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Physical Review Letters|January 7, 2003
The reaction gammap-->pi0gamma'p and the magnetic dipole moment of the Delta+ 1232 resonanceM Kotulla, J Ahrens, J R M Annand, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitorsZhen-Wei Cai, Donna Wei, Gretchen M Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2016
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitorsRajeev S Bhide, James Neels, Lan-Ying Qin, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studiesZilun Hu, Cailan Wang, Peter W Glunz, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2011
Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitorsAlaric J Dyckman, Tianle Li, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonistsBin Jiang, James J-W Duan, Sylwia Stachura, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2008
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitorsStephen T Wrobleski, Shuqun Lin, John Hynes, et al.
Thorax|November 4, 2024
Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung studyEmilia A Hermann, Amin Motahari, Eric A Hoffman, et al.
Pageof 25

Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Physical Review Letters|January 7, 2003
The reaction gammap-->pi0gamma'p and the magnetic dipole moment of the Delta+ 1232 resonanceM Kotulla, J Ahrens, J R M Annand, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitorsZhen-Wei Cai, Donna Wei, Gretchen M Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2016
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitorsRajeev S Bhide, James Neels, Lan-Ying Qin, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studiesZilun Hu, Cailan Wang, Peter W Glunz, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2011
Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitorsAlaric J Dyckman, Tianle Li, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonistsBin Jiang, James J-W Duan, Sylwia Stachura, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2008
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitorsStephen T Wrobleski, Shuqun Lin, John Hynes, et al.
Thorax|November 4, 2024
Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung studyEmilia A Hermann, Amin Motahari, Eric A Hoffman, et al.
Pageof 25